
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Comet C/2025 K1 (ATLAS) breaks apart in incredible telescope photos - 2
Vice President Dick Cheney’s life followed the arc of the biggest breakthroughs in cardiovascular medicine - 3
New peace laureate: Iran's arrest of Mohammadi 'confession of fear' - 4
Change Your Skincare: 10 Inventive Magnificence Gadgets - 5
Collins Foods to offload 20 Taco Bell outlets in Australia
April's full moon decides the date of Easter — here's how it works
Bowen Yang is reportedly leaving 'Saturday Night Live' after this week's episode
Reports: Germany plans expansion of foreign intelligence powers
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
Artemis II's moonbound toilet is working again to astronauts' relief after overnight fix
Moving Pool Highlights for 2024
Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs
Carrying on with a Sans plastic Way of life: Individual Examinations in Maintainability
From Overpowered to Coordinated: Individual Accounts of Cleaning up












